Randomized double‐blind placebo‐controlled cosmetic trial of a topical first‐in‐class Neutraligand targeting the chemokine TARC/CCL17 in mild‐to‐moderate atopic dermatitis.
Saved in:
| Title: | Randomized double‐blind placebo‐controlled cosmetic trial of a topical first‐in‐class Neutraligand targeting the chemokine TARC/CCL17 in mild‐to‐moderate atopic dermatitis. |
|---|---|
| Authors: | Frossard, Nelly1 (AUTHOR), Coïc, Alexandra2 (AUTHOR), Saguet, Thibaut3 (AUTHOR), Coïc, Alain2 (AUTHOR), Himbert, Franck2 (AUTHOR), Do, Quoc Tuan2 (AUTHOR), Galzi, Jean‐Luc4 (AUTHOR), Suehs, Carey5 (AUTHOR), Guillaumet, Gerald6 (AUTHOR), Bonnet, Pascal6 (AUTHOR), Bernard, Philippe2 (AUTHOR) philippe.bernard@greenpharma.com |
| Source: | International Journal of Cosmetic Science. Jun2024, Vol. 46 Issue 3, p468-477. 10p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
